The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of antibiotic exposure on the efficacy of immune checkpoint blockade in MSI-H metastatic CRC.
 
Victoria Serpas
No Relationships to Disclose
 
Jane Elizabeth Rogers
No Relationships to Disclose
 
Lianchun Xiao
No Relationships to Disclose
 
Kerri Mola-Rudd
No Relationships to Disclose
 
Arvind Dasari
Consulting or Advisory Role - Abbvie/Stemcentrx; Abbvie/Stemcentrx; Abbvie/Stemcentrx; Abbvie/Stemcentrx; Ipsen; Ipsen; Ipsen; Ipsen; Lexicon; Lexicon; Lexicon; Lexicon; Novartis; Novartis; Novartis; Novartis; Voluntis; Voluntis; Voluntis; Voluntis
Research Funding - eFFECTOR Therapeutics; eFFECTOR Therapeutics; eFFECTOR Therapeutics; eFFECTOR Therapeutics; Eisai; Eisai; Eisai; Eisai; Guardant Health; Guardant Health; Guardant Health; Guardant Health; Hutchison MediPharma; Hutchison MediPharma; Hutchison MediPharma; Hutchison MediPharma; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis
 
Bryan K. Kee
Stock and Other Ownership Interests - Medtronic; Medtronic; Medtronic; Medtronic
 
Michael J. Overman
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Gritstone Bio; Gritstone Bio; Gritstone Bio; Gritstone Bio; MedImmune; MedImmune; MedImmune; MedImmune; Novartis; Novartis; Novartis; Novartis; Promega; Promega; Promega; Promega; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MedImmune; MedImmune; MedImmune; MedImmune; Merck; Merck; Merck; Merck; Roche; Roche; Roche; Roche
 
Benny Johnson
No Relationships to Disclose